This report was recently updated on April 21 2024 with the latest and most recent
market numbers
India Digital Transformation in Pharma Industry Market Size, Trends & Analysis - Forecasts to 2029 By Technology (Cloud Computing, Artificial Intelligence (AI), Big Data Analytics, and Internet of Things (IoT)), By Application (Drug Discovery and Development, Clinical Trials, and Manufacturing), and By End User (Pharmaceutical Companies, Biotechnology Companies, and CROs and CMOs), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The India digital transformation in pharma industry market is projected to grow at a CAGR of 19.2% from 2024 to 2029.
The adoption of advanced technologies like AI, ML, and big data analytics is revolutionizing the Indian pharma industry. These tools enhance drug discovery, streamline clinical trials, and optimize supply chain management. By leveraging predictive analytics and data-driven insights, pharmaceutical companies in India are improving efficiency, reducing costs, and accelerating the pace of innovation in developing and delivering healthcare solutions.
The Indian pharmaceutical sector is emphasizing data security and regulatory adherence, aligning with benchmarks such as the Health Insurance Portability and Accountability Act (HIPAA) and worldwide regulations. This concentrated effort demonstrates the industry's commitment to protecting the security and integrity of healthcare data. Adherence to tight rules is critical for creating confidence in stakeholders and adding to the overall stability and robustness of digital healthcare systems in India.
Indian government programs actively support e-health and digital healthcare services, resulting in the broad digitization of healthcare records, prescription systems, and patient management. These endeavors seek to improve the accessibility, efficiency, and quality of healthcare services by harnessing digital technologies. The emphasis on digitization is consistent with the goal of establishing a more integrated and technologically advanced healthcare ecosystem to improve patient care and overall health outcomes.
Inadequate technological infrastructure, particularly in rural regions, might limit the implementation of digital solutions, reducing connectivity, accessibility, and the effectiveness of digital healthcare services.
The cloud computing segment is expected to hold the largest share of the market. This is due to its scalability, flexibility, and cost-effectiveness. Cloud solutions enable seamless collaboration, data storage, and processing, allowing pharmaceutical companies to improve efficiency in research, development, and distribution. With a focus on data-driven insights and collaborative platforms, cloud computing emerges as a critical technology, contributing to market growth.
The artificial intelligence (AI) segment is expected to be the fastest-growing segment in the market from 2024 to 2029. The anticipated growth is due to the increasing integration of AI in the pharmaceutical business. AI helps with data analytics, predictive maintenance, and autonomous decision-making, which increases efficiency. AI's ability to adapt and learn from data patterns makes them critical components of digital transformation in the pharmaceutical business, contributing to segment growth.
The manufacturing segment is anticipated to be the fastest-growing segment in the market from 2024-2029. The segment's growth is attributed to the greater emphasis on operational efficiency and quality control. Digital transformation technologies improve industrial processes by assuring precision, quality assurance, and supply chain management.
The drug discovery and development segment is expected to hold the largest share of the market. The expected growth is due to the impact of digitalization on the pharma industry's research processes. AI and big data analytics are examples of advanced technologies that help in drug discovery, clinical trials, and R&D process optimization. This application promises higher efficiency, lower costs, and greater innovation, contributing to the Indian digital transformation in pharma industry market growth.
The CROs and CMOs segment is anticipated to be the fastest-growing segment in the market from 2024-2029. As pharmaceutical and biotech businesses outsource more research and manufacturing activities to specialized service providers, the demand for CROs and CMOs grows. These organizations use digital transformation to improve efficiency in clinical trial management, data analytics, and manufacturing processes, further contributing to the segment's growth.
The pharmaceutical companies segment is expected to hold the largest share of the market. The expected growth of the segment is due to its dependency on technological advancements. Digital transformation is critical in improving research and development, streamlining industrial processes, optimizing supply networks, and maintaining regulatory compliance. As pharmaceutical businesses seek to remain competitive in an ever-changing industry, the usage of digital technology becomes increasingly important, leading to the segment's greatest market share among end users.
Electrosan Technologies, Khodke Cloud Solutions, Microsoft Corporation, Oracle Corporation, ABB, Honeywell International Inc., Cisco Systems, Inc., Siemens Healthcare GmbH, GE Healthcare, and IBM Corporation, among others, are some of the key players operating in the India digital transformation in pharma industry market.
Please note: This is not an exhaustive list of companies profiled in the report.
In August 2023, ABB India announced a significant automation contract secured from Reliance Life Sciences (RLS) to automate their new manufacturing plants in Nashik, Maharashtra. ABB will deploy its flagship Distributed Control System (DCS) Ability System 800xA to automate the biosimilars and plasma proteins manufacturing facilities.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 INDIA MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 INDIA DIGITAL TRANSFORMATION IN PHARMA INDUSTRY MARKET, BY TECHNOLOGY
4.1 Introduction
4.2 Digital Transformation in Pharma Industry Market: Technology Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Cloud Computing
4.4.1 Cloud Computing Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Artificial Intelligence (AI)
4.5.1 Artificial Intelligence (AI) Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Big Data Analytics
4.6.1 Big Data Analytics Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Internet of Things (IoT)
4.7.1 Internet of Things (IoT) Market Estimates and Forecast, 2021-2029 (USD Million)
5 INDIA DIGITAL TRANSFORMATION IN PHARMA INDUSTRY MARKET, BY APPLICATION
5.1 Introduction
5.2 Digital Transformation in Pharma Industry Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Drug Discovery and Development
5.4.1 Drug Discovery and Development Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Clinical Trials
5.5.1 Clinical Trials Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Manufacturing
5.6.1 Manufacturing Market Estimates and Forecast, 2021-2029 (USD Million)
6 INDIA DIGITAL TRANSFORMATION IN PHARMA INDUSTRY MARKET, BY END USER
6.1 Introduction
6.2 Digital Transformation in Pharma Industry Market: End User Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Pharmaceutical Companies
6.4.1 Pharmaceutical Companies Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 Biotechnology Companies
6.5.1 Biotechnology Companies Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 CROs and CMOs
6.6.1 CROs and CMOs Market Estimates and Forecast, 2021-2029 (USD Million)
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Electrosan Technologies
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Khodke Cloud Solutions
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Microsoft Corporation
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Oracle Corporation
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 ABB
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 Honeywell International Inc.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Cisco Systems, Inc.
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Siemens Healthcare GmbH
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 GE Healthcare
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 IBM Corporation
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.7.1 Research Assumptions
8.7.2 Research Limitations
LIST OF TABLES
1 India Digital Transformation in Pharma Industry Market, By Technology, 2021-2029 (USD Million)
2 Cloud Computing Market, By Country, 2021-2029 (USD Million)
3 Artificial Intelligence (AI) Market, By Country, 2021-2029 (USD Million)
4 Big Data Analytics Market, By Country, 2021-2029 (USD Million)
5 Internet of Things (IoT) Market, By Country, 2021-2029 (USD Million)
6 India Digital Transformation in Pharma Industry Market, By Application, 2021-2029 (USD Million)
7 Drug Discovery and Development Market, By Country, 2021-2029 (USD Million)
8 Clinical Trials Market, By Country, 2021-2029 (USD Million)
9 Manufacturing Market, By Country, 2021-2029 (USD Million)
10 India Digital Transformation in Pharma Industry Market, By End User, 2021-2029 (USD Million)
11 Pharmaceutical Companies Market, By Country, 2021-2029 (USD Million)
12 Biotechnology Companies Market, By Country, 2021-2029 (USD Million)
13 CROs and CMOs Market, By Country, 2021-2029 (USD Million)
14 Country Analysis, 2021-2029 (USD Million)
15 Electrosan Technologies: Products & Services Offering
16 KHODKE CLOUD SOLUTIONS: Products & Services Offering
17 Microsoft Corporation: Products & Services Offering
18 Oracle Corporation: Products & Services Offering
19 ABB: Products & Services Offering
20 HONEYWELL INTERNATIONAL INC.: Products & Services Offering
21 Cisco Systems, Inc. : Products & Services Offering
22 Siemens Healthcare GmbH: Products & Services Offering
23 GE Healthcare, Inc: Products & Services Offering
24 IBM Corporation: Products & Services Offering
25 Other Companies: Products & Services Offering
LIST OF FIGURES
1 India Digital Transformation in Pharma Industry Market Overview
2 India Digital Transformation in Pharma Industry Market Value From 2021-2029 (USD Million)
3 India Digital Transformation in Pharma Industry Market Share, By Technology (2023)
4 India Digital Transformation in Pharma Industry Market Share, By Application (2023)
5 India Digital Transformation in Pharma Industry Market Share, By End User (2023)
6 Technological Trends In India Digital Transformation in Pharma Industry Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The India Digital Transformation in Pharma Industry Market
10 Impact Of Challenges On The India Digital Transformation in Pharma Industry Market
11 Porter’s Five Forces Analysis
12 India Digital Transformation in Pharma Industry Market: By Technology Scope Key Takeaways
13 India Digital Transformation in Pharma Industry Market, By Technology Segment: Revenue Growth Analysis
14 Cloud Computing Market, By Country, 2021-2029 (USD Million)
15 Artificial Intelligence (AI) Market, By Country, 2021-2029 (USD Million)
16 Big Data Analytics Market, By Country, 2021-2029 (USD Million)
17 Internet of Things (IoT) Market, By Country, 2021-2029 (USD Million)
18 India Digital Transformation in Pharma Industry Market: By Application Scope Key Takeaways
19 India Digital Transformation in Pharma Industry Market, By Application Segment: Revenue Growth Analysis
20 Drug Discovery and Development Market, By Country, 2021-2029 (USD Million)
21 Clinical Trials Market, By Country, 2021-2029 (USD Million)
22 Manufacturing Market, By Country, 2021-2029 (USD Million)
23 India Digital Transformation in Pharma Industry Market: By End User Scope Key Takeaways
24 India Digital Transformation in Pharma Industry Market, By End User Segment: Revenue Growth Analysis
25 Pharmaceutical Companies Market, By Country, 2021-2029 (USD Million)
26 Biotechnology Companies Market, By Country, 2021-2029 (USD Million)
27 CROs and CMOs Market, By Country, 2021-2029 (USD Million)
28 Country Segment: Revenue Growth Analysis
29 India Digital Transformation in Pharma Industry Market: Country Analysis
30 India Digital Transformation in Pharma Industry Market Overview
31 Four Quadrant Positioning Matrix
32 Company Market Share Analysis
33 Electrosan Technologies: Company Snapshot
34 Electrosan Technologies: SWOT Analysis
35 Electrosan Technologies: Geographic Presence
36 Khodke Cloud Solutions: Company Snapshot
37 Khodke Cloud Solutions: SWOT Analysis
38 Khodke Cloud Solutions: Geographic Presence
39 Microsoft Corporation: Company Snapshot
40 Microsoft Corporation: SWOT Analysis
41 Microsoft Corporation: Geographic Presence
42 Oracle Corporation: Company Snapshot
43 Oracle Corporation: Swot Analysis
44 Oracle Corporation: Geographic Presence
45 ABB: Company Snapshot
46 ABB: SWOT Analysis
47 ABB: Geographic Presence
48 Honeywell International Inc.: Company Snapshot
49 Honeywell International Inc.: SWOT Analysis
50 Honeywell International Inc.: Geographic Presence
51 Cisco Systems, Inc. : Company Snapshot
52 Cisco Systems, Inc. : SWOT Analysis
53 Cisco Systems, Inc. : Geographic Presence
54 Siemens Healthcare GmbH: Company Snapshot
55 Siemens Healthcare GmbH: SWOT Analysis
56 Siemens Healthcare GmbH: Geographic Presence
57 GE Healthcare, Inc.: Company Snapshot
58 GE Healthcare, Inc.: SWOT Analysis
59 GE Healthcare, Inc.: Geographic Presence
60 IBM Corporation: Company Snapshot
61 IBM Corporation: SWOT Analysis
62 IBM Corporation: Geographic Presence
63 Other Companies: Company Snapshot
64 Other Companies: SWOT Analysis
65 Other Companies: Geographic Presence
The India Digital Transformation in Pharma Industry Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the India Digital Transformation in Pharma Industry Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
